Biotech

All Articles

Praxis epilepsy medicine minimizes confiscations in period 2 hearing

.Praxis Precision Medicines has racked up yet another midphase win in epilepsy this year, along with...

Three execs resign as Dyne messages combined data for DMD candidate

.After getting away from a scientific hold many years back, Dyne Therapy has revealed new period 1/2...

Arrowhead fires off period 3 data in unusual metabolic health condition before market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its give in advance of a potential showdown along with Ionis...

Pfizer, Valneva present lyme ailment try successful for second enhancer

.Pfizer as well as Valneva might have concerning pair of even more years to wait prior to they produ...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a chat with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle Benz as they expl...

New records show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the stage 3 test for its variable XIa inhibitor asundexian late in 2013 after the d...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stockpile as fund shows intent to mold its development

.Galapagos is coming under extra pressure coming from financiers. Having developed a 9.9% stake in G...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has gotten on its own a starring job in China's KRAS market, paying...